PREGNANCY occurring in women with chronic liver disease is very rare. Deliveries in cirrhotics have, however, been reported (Slater, 1954 ; Moore & Hughes, 1960; Dreifus & McKinney, 1966; McArthur & Flax, 1968) , and cases of active chronic hepatitis, treated with steroids, have also come to term successfully (Beam, Kunkel & Slater, 1956; Jackson, 1962; Seedat & Raine, 1965) . Recently azathioprine, an immunosuppressive agent, has been used with good effect in the treatment of active chronic hepatitis (Mackay, Weiden & Ungar, 1964; Corley, 1966) . Azathioprine is teratogenic in animals (Githens, Rosenkrantz & Tunnock, 1965; Rosenkrantz et al., 1967) Investigations showed a total serum bilirubin of 11-6 g/100 ml, serum alkaline phosphatase 16 KA units, serum glutamic oxaloacetic transaminase (SGOT) 105 units/ml, and total serum proteins of 11 g/100 ml, with an albumin of 2-8 g/100 ml and y-globulin of 6-6 g/100 ml. LE (Harvald, 1967) (Mistilis & Blackburn, 1967 al., 1967) . It is also teratogenic in rabbits and dogs. Fertility of the adult mouse, however, is unaffected. In humans, the number of cases in which pregnancy has occurred whilst on azathioprine is so low that the effects on the foetus at present cannot be assessed.
